Actively Recruiting
Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms
Led by University Hospital Tuebingen · Updated on 2025-01-17
580
Participants Needed
1
Research Sites
830 weeks
Total Duration
On this page
Sponsors
U
University Hospital Tuebingen
Lead Sponsor
U
University Hospital Heidelberg
Collaborating Sponsor
AI-Summary
What this Trial Is About
Evaluation of clinical, therapeutic and prognostic relevance of new experimental results as well as optimization of therapeutic models and development of a new algorithm for therapeutic plan and therapy in patients with uterine neoplasm
CONDITIONS
Official Title
Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed uterine malignancy (cervical cancer, endometrial cancer, sarcoma)
- If operable: planned primary surgical therapy via laparoscopic, robot-assisted, or open radical gyneco-oncological surgery
- Written consent to participate
- Willingness and ability to undergo all study procedures
- Age 18 years or older
You will not qualify if you...
- Severe or acute general disease within the last 4 weeks
- Acute or chronic psychiatric disorders
- Factors affecting study participation such as acute psychosocial stress, insufficient understanding of the study's nature and consequences, or inadequate German language skills
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Tuebingen, Department of Women's Health
Tübingen, Germany, 72076
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here